M

MBRX

MBRX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
71%Bullish
Buy/Sell Ratio100% buys
BearishBullish
MBRX Live QuoteReal-time
$7.93
+$1.62(+25.67%)1M
Day Range$6.71 – $8.96
Open$6.72
Previous Close$6.75
Volume153.6K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$8.00M
P/E Ratio (TTM)0.0
Forward P/ENaN
EPS (TTM)$179.60
Price to Book0.6
Dividend Yield0.65%
Beta (Volatility)2.09
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $7.93 (2%)
Low: $3.23High: $222.70
Wall Street Consensus
Strong Buy
Analyst Rating
4.8/ 5.0
Target Price
$240.00+60.0% upside

Insider Buys

5

$350K

Insider Sales

0

$0

Total Volume

$350K

7 transactions

Net Activity

+$350K

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
100CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Cluster buying: 3 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys2 sells

$167.39B total

K
2

Klemp Walter V

CEO, Pres

2 buys0 sells

$250K total

F
3

Foster Jonathan P.

CFO

2 buys0 sells

$100K total

P
4

Picker Donald H

Chief Science Officer

1 buys0 sells

$0 total

Trading History
MBRX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Aug 3, 2026

3 months ago

Klemp Walter V

CEO, Pres

CEO
Buy533.3K$0.00$0

Aug 3, 2026

3 months ago

Foster Jonathan P.

CFO

CFO
Buy293.3K$0.00$0

Aug 3, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell305.7K$293333.00$89.66B

Aug 3, 2026

3 months ago

Picker Donald H

Chief Science Officer

C-Level
Buy173.3K$0.00$0

Jun 23, 2025

17 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell287.6K$270270.00$77.73B

Jun 23, 2025

17 months ago

Klemp Walter V

CEO, Pres

CEO
Buy675.7K$0.37$250K

Jun 23, 2025

17 months ago

Foster Jonathan P.

CFO

CFO
Buy270.3K$0.37$100K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
MBRX Buy Conviction100%
Industry Rank#0 of 570
Volume Contribution0.0%
Total Industry Activity$16.44B

MBRX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for MBRX

Over the last 90 days, corporate insiders at MBRX (MBRX) engaged in a total of 7 transactions reported via SEC Form 4 filings. Among these, 5 were open-market purchases and 0 were sales. The total volume of insider trading reached $350K.

The net insider activity for MBRX shows a net buying bias of $350K. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 305.7K shares valued at $89.66B on Aug 3, 2026.

Live Market News & Developments
Aggregated real-time headlines for MBRX (MBRX)
6 updates

Moleculin Biotech, Inc. (MBRX) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Moleculin Biotech, Inc. (MBRX) stock price, news, quote and history

Yahoo Finance UKYesterday

John M. Climaco received 4,000 options to buy Moleculin Biotech (MBRX) shares at $6.83 each.

Stock Titan3h ago

Moleculin Biotech Stock Price Forecast. Should You Buy MBRX?

StockInvest.us8d ago

MBRX - Moleculin Biotech Inc Stock Price and Quote

Finviz176d ago

Director Michael D. Cannon received 4,000 options in Moleculin Biotech (MBRX) at a $6.83 exercise price.

Stock Titan3h ago

FAQs About MBRX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for MBRX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for MBRX is currently 100/100, which reflects a strong accumulation bias. This calculation accounts for a total of 5 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for MBRX is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.